Skip to main content
. 2022 Jan 7;17(8):1675–1684. doi: 10.4103/1673-5374.332128

Table 4.

Lignans as inhibitors of TNF-α and neuroinflammatory responses in neurodegenerative diseases

Lignans Source Disease Mechanism IC50/dose Model Reference
Schisandrin A Schisandra chinesnesis PD Inhibits the production of NO, TNF-α and IL-6 10, 20 and 50 μM Rat cortical cells Song et al., 2016
Schisandrin B (Gomisin N) Schisandra chinesnesis PD Suppresses the expression of NO, TNF-α, PGE-2, IL-1β and IL-6 5, 10 or 20 mM Rat primary neuron–microglia Zeng et al., 2012
Schisandrin B (Gomisin N) Schisandra chinensis PD Decreases indoleamine 2,3 dioxygenase expression, and TNF-α, IL-1β and IL-6 10 mg/kg/d Mice Sun et al., 2014
Honokiol, magnolol Magnolia officinalis AD Induces NGF and BDNF secretion, inhibits TNF-α, NF-κB, IL-1β, IL-6, and ROS levels, and increases Akt activity 100, 50, 10, and 1 μM PC12 cells Hoi et al., 2010

AD: Alzheimer’s disease; ERK: extracellular signal-regulated kinase; iNOS: inducible nitric oxide synthase; NGF: nerve growth factor; PD: Parkinson’s disease; ROS: reactive oxygen species; TNFα: tumor necrosis factor alpha; TNFR: tumor necrosis factor alpha receptor.